← Back to headlines
Weight-Loss Drugs Linked to Unmonitored Changes in Women
A new analysis of a US adverse event database suggests GLP-1 weight-loss drugs are associated with changes in women that were not tracked during clinical trials, beyond their known digestive side effects.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
